Selecky Christobel sold IBRX
January 16, 2026 · Form 4 insider transaction
Selecky Christobel sold 50,000 shares of ImmunityBio, Inc. at $5.00 per share, a transaction worth $250.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
50,000
Price
$5.00
Total value
$250.0K
InsiderSelecky Christobel
Role—
CompanyImmunityBio, Inc. (IBRX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.